-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Akoya Biosciences, Inc. quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 31 Mar 2020 to 31 Mar 2025.
- Akoya Biosciences, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 31 Mar 2025 was $16,639,000, a 9.3% decline year-over-year.
- Akoya Biosciences, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending 31 Mar 2025 was $79,961,000, a 15% decline year-over-year.
- Akoya Biosciences, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $81,672,000, a 15% decline from 2023.
- Akoya Biosciences, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $96,633,000, a 29% increase from 2022.
- Akoya Biosciences, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $74,859,000, a 36% increase from 2021.